Mehta, Rashmi
Farrell, Colm
Hayes, Siobhán
Birk, Ruby
Okour, Malek
Lipson, David A. http://orcid.org/0000-0001-6732-4593
Funding for this research was provided by:
GlaxoSmithKline (200812 (NCT02729051), CTT116853 (NCT02345161), CTT116855 (NCT02164513))
Article History
First Online: 19 July 2019
Compliance with Ethical Standards
:
: Funding for these studies [200812 (NCT02729051); CTT116853 (NCT02345161); CTT116855 (NCT02164513)] was provided by GlaxoSmithKline. The funders of the study had a role in the study design, data analysis, data interpretation, and writing of the report. The corresponding author had full access to all the data and the final responsibility to submit for publication. All authors meet the criteria for authorship set forth by the International Committee for Medical Journal Editors.
: Rashmi Mehta, Ruby Birk, Malek Okour, and David A. Lipson are employees of GSK and hold stock in the company. Colm Farrell and Siobhán Hayes are employees of ICON; ICON received funding from GSK to conduct the analysis.
: The study protocols were approved by the appropriate institutional review boards and conducted in accordance with good clinical practice guidelines and the Declaration of Helsinki. The human biological samples were sourced ethically and their research use was in accordance with the terms of the informed consents.
: All subjects enrolled in the studies included in this analysis were required to provide written informed consent prior to any study-related procedures.
: Anonymized individual participant data and study documents can be requested for further research from ExternalRef removed.